活性氧
下调和上调
肾小管病变
血管紧张素II
化学
内科学
血管紧张素转换酶
酶
内分泌学
肾素-血管紧张素系统
生物化学
生物
医学
肾
受体
基因
血压
作者
Xia-Qing Li,Zhang-Zhang Xiao,Ke Ma,X.-L. Liu,Huan‐Huan Liu,Bo Hu,Qian Zhao,Hong-Yue Li,Ruichang Chen,Yu Meng,Lianghong Yin
标识
DOI:10.1089/ars.2024.0637
摘要
Aims: The limited therapeutic options for diabetic tubulopathy (DT) in early diabetic kidney disease (DKD) reflect the difficulty of targeting renal tubular compartment. While renin–angiotensin–aldosterone system (RAS) inhibitors are commonly utilized in the management of DKD, how intrarenal RAS contributes to diabetic tubular injury is not fully understood. Mitochondrial disruption and reactive oxygen species (ROS) overgeneration have been involved in diabetic tubular injury. Herein, we aim to test the hypothesis that angiotensin-converting enzyme (ACE)-dependent intrarenal angiotensin II (AngII) disrupts tubular mitochondrial membranous homeostasis and causes excessive ROS generation in DT.
科研通智能强力驱动
Strongly Powered by AbleSci AI